Novo Nordisk Office Near Copenhagen Headquarters Hit by Fire
By Helena Smolak
Novo Nordisk contained a fire outbreak at a leased office building close to its headquarters in the Copenhagen suburb of Bagsvaerd, following prior blazes at company facilities in May.
The Danish drug maker--known for its weight-loss drugs Wegovy and Ozempic--said there weren't any indications that the latest blaze, whose cause remains unknown, is linked to the previous incidents or criminal activity.
"This afternoon a fire broke out in connection with roof work on an office building. The fire is under control and has not spread to any surrounding buildings," a spokesman for the company said.
The fire brigade and police are currently on site, the spokesman added.
Last month, fires occurred at a separate Novo Nordisk facility in Bagsvaerd and at a manufacturing site in Kalundborg, a city west of Copenhagen where the company produces its active pharmaceutical ingredients for diabetes and weight-loss drugs.
Write to Helena Smolak at helena.smolak@wsj.com
(END) Dow Jones Newswires
June 18, 2024 12:34 ET (16:34 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations